We are live on ! Find out more
MP

Mangrove Partners Portfolio holdings

AUM $1.24B
1-Year Est. Return 41.74%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+41.74%
3 Year Est. Return
+169.22%
5 Year Est. Return
+150.23%
10 Year Est. Return
+417.9%
AUM
$991M
AUM Growth
+$260M
Cap. Flow
+$254M
Cap. Flow %
25.68%
Top 10 Hldgs %
35.1%
Holding
398
New
299
Increased
7
Reduced
3
Closed
88
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PUCKW
276
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$119K 0.01%
+270,827
New +$135K
EQHA.WS
277
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
$112K 0.01%
+224,250
New +$130K
LEGOW
278
DELISTED
Legato Merger Corp. Warrant
LEGOW
$112K 0.01%
+233,614
New +$133K
RKTA.U
279
DELISTED
Rocket Internet Growth Opportunities Corp. Units, each consisting of one Class A ordinary share and one-fourth of one redeemable warrant
RKTA.U
$100K 0.01%
+10,000
New +$100K
NGC.U
280
DELISTED
Northern Genesis Acquisition Corp. III Units, each consisting of one share of common stock and one-quarter of one redeemable warrant
NGC.U
$100K 0.01%
+10,000
New +$99.4K
GGMCU
281
DELISTED
Glenfarne Merger Corp. Unit
GGMCU
$99K 0.01%
+10,000
New +$99.2K
GGPIU
282
DELISTED
Gores Guggenheim, Inc. Unit
GGPIU
$99K 0.01%
+10,000
New +$99.5K
SCLXW icon
283
Scilex Holding Co Warrant
SCLXW
$1.86M
$97K 0.01%
+221,294
New +$118K
ISLEW
284
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$92K 0.01%
+196,441
New +$94K
BIOTW
285
DELISTED
Biotech Acquisition Company Warrant
BIOTW
$90K 0.01%
+150,000
New +$106K
MDH.WS
286
DELISTED
MDH Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
MDH.WS
$90K 0.01%
+150,000
New +$95K
PRSTW
287
DELISTED
Presto Technologies, Inc. Warrant
PRSTW
$85K 0.01%
+193,327
New +$117K
EPWR.WS
288
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$80K 0.01%
+160,395
New +$102K
GCACW
289
DELISTED
Growth Capital Acquisition Corp. Warrant
GCACW
$77K 0.01%
+150,000
New +$81.2K
MIT.WS
290
DELISTED
Mason Industrial Technology, Inc. Redeemable warrants, exercisable for one share of Class A common stock for $11.50 per share
MIT.WS
$63K 0.01%
+100,000
New +$65.3K
ESSCW
291
DELISTED
East Stone Acquisition Corporation Warrant
ESSCW
$61K 0.01%
+240,760
New +$125K
DNZ.WS
292
DELISTED
D and Z Media Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
DNZ.WS
$60K 0.01%
+100,000
New +$66.4K
TLGA.WS
293
DELISTED
TLG Acquisition One Corp. Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
TLGA.WS
$57K 0.01%
+100,000
New +$63K
CAHCW
294
DELISTED
CA Healthcare Acquisition Corp. Warrant
CAHCW
$53K 0.01%
+100,000
New +$76.1K
EACPW
295
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$52K 0.01%
+103,825
New +$60.7K
REVBW icon
296
Revelation Biosciences Warrant
REVBW
$9.41K
$49K ﹤0.01%
+95,100
New +$88.9K
VOSOW
297
DELISTED
Virtuoso Acquisition Corp. Warrant
VOSOW
$47K ﹤0.01%
+77,841
New +$47.6K
CLRMW
298
DELISTED
Clarim Acquisition Corp. Warrant
CLRMW
$44K ﹤0.01%
+70,233
New +$48.4K
MONCW
299
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
$42K ﹤0.01%
+84,475
New +$50.2K
BLUA.WS
300
DELISTED
BlueRiver Acquisition Corp. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50
BLUA.WS
$29K ﹤0.01%
+46,428
New +$42K

Similar funds

Mangrove Partners's Q1 2021 Portfolio in Review

As of Q1 2021, Mangrove Partners held 398 positions worth $991M, up 36% from $731M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Mangrove Partners deployed $254M of net new capital in Q1 2021, opening 299 new positions and adding to 7 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 7.8% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Navios Maritime Containers L.P. Common Units, an estimated $12.7M trimmed.

  • Mangrove Partners's largest Q1 2021 buy was Alexion Pharmaceuticals: 113,349 shares worth $17.3M.
  • Mangrove Partners added most to Pershing Square Tontine Holdings, Ltd. in Q1 2021, an estimated $27.1M increase.
  • Mangrove Partners's biggest Q1 2021 reduction was Navios Maritime Containers L.P. Common Units, cutting an estimated $12.7M.
  • Mangrove Partners fully exited TG Therapeutics in Q1 2021, selling an estimated $17.7M.
  • Mangrove Partners's ten largest holdings make up 35% of its $991M portfolio in Q1 2021.
  • Mangrove Partners opened 299 new positions and closed 88 in Q1 2021.
  • Mangrove Partners's portfolio value rose 36% quarter-over-quarter to $991M.

Based on Mangrove Partners's 13F filing for Q1 2021, filed 17 May 2021.